Physician

Timothy Hancock Dorius, M.D.

According to 2025 Medicare claims, Timothy Dorius, M.D. (NPI: 1689961484) practices internal medicine in the Omaha, NE-IA market, with the plurality of this provider's patient population coming from Douglas, NE. This provider's primary affiliated billing organization is ONCOLOGY HEMATOLOGY WEST, PC (NPI: 1932178530; TIN: 470754790) and primary practice location at 68114-4108. Dorius is affiliated with the NPG Health Collaborative LLC (ACO ID: A3287), Bryan Health Connect ACO, LLC (ACO ID: A4573), and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Dorius' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 405 traditional Medicare patients, billed 135,209 HCPCS/CPT codes, and received $2,249,882 in Medicare payments. The top billing code was 99205 (New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more). Part D data shows 1,056 prescription claims across 214 beneficiaries totaling $2,261,088 in drug costs, led by Lenalidomide (Lenalidomide). 2021 DME data shows 66 claims. Open Payments data shows 39 records totaling $18,088. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,225 to $2,249,882. Similarly, Part D prescription costs have risen steadily, from $13,793 to $2,261,088. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	11	11	$1,225
2016	N/R	N/R	N/R
2017	368	36,535	$491,933
2018	705	149,977	$1,719,498
2019	352	101,828	$1,116,428
2020	315	126,735	$1,197,884
2021	307	123,641	$1,936,692
2022	262	183,797	$2,195,661
2023	403	192,518	$2,948,977
2024	405	135,209	$2,249,882

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	52	250	$13,793
2016	21	155	$7,811
2017	46	108	$18,549
2018	98	303	$235,167
2019	123	651	$1,102,604
2020	142	858	$1,215,526
2021	150	861	$1,339,104
2022	150	737	$1,214,483
2023	187	987	$1,580,904
2024	214	1,056	$2,261,088

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	66	$41,033
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	60	60	$134
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	62	95	$114
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	282	704	$80
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	102	114	$12
J7050	Infusion, normal saline solution, 250 cc	63	444	$0

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Lenalidomide	Lenalidomide	49	1,372	$659,883
Revlimid	Lenalidomide	16	448	$290,130
Alunbrig	Brigatinib	14	397	$265,990
Lynparza	Olaparib	12	360	$191,914
Eliquis	Apixaban	35	1,360	$26,866

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	37	$6,965	Gilead Sciences, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	2	$11,123	Napo Pharmaceuticals Inc
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Timothy Hancock Dorius, M.D.?

Tedicare shows public-source Medicare data for Timothy Hancock Dorius, M.D. (NPI 1689961484), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Timothy Hancock Dorius, M.D. have ACO affiliation data?

Timothy Hancock Dorius, M.D. is shown with ACO affiliation data for NPG Health Collaborative LLC (MSSP, ACO ID A3287), Bryan Health Connect ACO, LLC (MSSP, ACO ID A4573), and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Timothy Hancock Dorius, M.D.?

Timothy Hancock Dorius, M.D. is linked to ONCOLOGY HEMATOLOGY WEST, PC (billing NPI 1932178530) in the available physician profile data.

Does Timothy Hancock Dorius, M.D. have Open Payments data?

Timothy Hancock Dorius, M.D. has 39 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.